Impact of Myocardial Ischemia and Revascularization by Percutaneous Coronary Intervention on Circulating Level of Soluble ST2.
Areej AlkhateebHossam Eldin M MahmoudMohammed AkMohammed H HassanAbdel Rahim Mahmoud MuddathirAhmed G BakryPublished in: Vascular health and risk management (2023)
A significantly high plasma level of sST2 in patients with myocardial ischemia and controlled cardiovascular risk factors showed an immediate reduction after successful revascularization. The high baseline level of the sST2 marker and the acute post-PCI reduction was mainly related to the severity of ischemia rather than left ventricular function.
Keyphrases
- percutaneous coronary intervention
- left ventricular
- cardiovascular risk factors
- acute myocardial infarction
- coronary artery bypass grafting
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- acute coronary syndrome
- antiplatelet therapy
- heart failure
- liver failure
- hypertrophic cardiomyopathy
- metabolic syndrome
- atrial fibrillation
- respiratory failure
- drug induced
- type diabetes
- aortic stenosis
- mitral valve
- transcatheter aortic valve replacement
- ejection fraction
- aortic dissection